LXEO Lexeo Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 12, 2026
$3.53
· of 52w range
· above low
· to high
$2.9852w low
$10.9952w high
Market Cap (MRQ)
$278M
P/E
-1.9
EPS
$-1.86
your badges
52W Range
$3–$11
Analyst Rating
STRONG BUY
Price Target
$20
P/E
-1.9
ROE
-51.9%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
LXEO Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.53
Market Cap (MRQ)
$278M
P/E
-1.9
EPS
$-1.86
ROE
-51.9%
52W Range
$3–$11
LXEO Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2022-12-31 → 2022-12-31
EPS$-1.862022-12-31 → 2025-12-31
Free Cash Flow$-99M2023-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | LXEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.95Y avg ≈-2.9 | ≈-2.9 | · | · | |
| P/B (MRQ) | 1.25Y avg ≈2.7 | ≈2.7 | 3.0 | Undervalued | |
| Price / FCF (TTM) | -3.15Y avg ≈-5.3 | ≈-5.3 | · | · | |
| Price / Cash Flow (TTM) | -3.15Y avg ≈-5.3 | ≈-5.3 | · | · | |
| Price / Tangible Book | 1.05Y avg ≈2.7 | ≈2.7 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | LXEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -48.1%5Y avg ≈-57.6% | ≈-57.6% | -31.8% | Weak | |
| ROE | -51.9%5Y avg ≈46.9% | ≈46.9% | -41.9% | Weak | |
| ROIC | -44.3% | · | -1.3% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | LXEO | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 13.95Y avg ≈8.0 | ≈8.0 | 4.7 | Strong liquidity | |
| Quick Ratio | 3.75Y avg ≈5.4 | ≈5.4 | 4.5 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
9.6%
Next Report
Nov 09, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 19, 2026 | $-0.30 | $-0.29 | -3.2% |
| March 31, 2026 | May 11, 2026 | $-0.25 | $-0.32 | 21.8% |
| Dec. 31, 2025 | $-0.27 | $-0.32 | 15.8% | |
| Sept. 30, 2025 | $-0.33 | $-0.53 | 37.8% | |
| June 30, 2025 | $-0.60 | $-0.69 | 13.5% | |
| March 31, 2025 | $-0.99 | $-0.80 | -23.9% | |
| Dec. 31, 2024 | $-0.78 | $-0.82 | 5.3% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | · | · | · | $654.0K | |
| R&D Expense | $64M | $74M | $53M | $49M | |
| SG&A Expense | $45M | $32M | $15M | $12M | |
| Operating Expenses | $109M | $106M | $69M | $61M | |
| Operating Income | $-109M | $-106M | $-69M | $-61M | |
| Interest Expense | · | · | $205.0K | $91.0K | |
| Interest Income | $6M | $8M | $3M | $1M | |
| Other Non-op | $-18.0K | $-9.0K | $-13.0K | $-2.0K | |
| Pretax Income | $-100M | $-98M | $-66M | $-59M | |
| Income Tax | $0 | $0 | · | · | |
| Net Income | $-100M | $-98M | $-66M | $-59M | |
| EPS (Basic) | $-1.86 | $-3.09 | $-12.40 | $-36.36 | |
| EPS (Diluted) | $-1.86 | $-3.09 | $-12.40 | $-36.36 | |
| Shares (Basic) | 53,645,323 | 31,787,491 | 5,354,368 | 1,630,348 | |
| Shares (Diluted) | 53,645,323 | 31,787,491 | 5,354,368 | 1,630,348 | |
| EBITDA | $-109M | $-106M | $-69M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $35M | $121M | $77M | |
| Short-term Investments | · | $87M | · | · | |
| Prepaid Expense | $7M | $5M | $3M | $2M | |
| Other Current Assets | · | · | $3.0K | $371.0K | |
| Current Assets | $188M | $126M | $124M | $80M | |
| PP&E (Net) | $1M | $1M | $1M | $998.0K | |
| PP&E (Gross) | $2M | $2M | $1M | $1M | |
| Accum. Depreciation | $741.0K | $474.0K | $381.0K | $133.0K | |
| Total Assets | $269M | $147M | $140M | $97M | |
| Accounts Payable | $5M | $6M | $4M | $3M | |
| Current Liabilities | $17M | $23M | $17M | $14M | |
| Capital Leases | $5M | $6M | $8M | $9M | |
| Total Liabilities | $22M | $30M | $26M | $25M | |
| Common Stock | $7.0K | $3.0K | $3.0K | $0 | |
| Retained Earnings | $-380M | $-280M | $-182M | $-115M | |
| Treasury Stock | $17.0K | $17.0K | · | · | |
| AOCI | $188.0K | $-103.0K | · | · | |
| Stockholders' Equity | $247M | $117M | $114M | $-113M | |
| Liabilities + Equity | $269M | $147M | $140M | $97M | |
| Shares Outstanding | 73,001,350 | 33,071,261 | 26,646,378 | 1,607,185 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $268.0K | $304.0K | $271.0K | $120.0K | |
| Stock-based Comp | $12M | $12M | $3M | $2M | |
| Operating Cash Flow | $-99M | $-81M | $-59M | $-55M | |
| CapEx | $397.0K | $481.0K | $115.0K | $672.0K | |
| Investing Cash Flow | $-90M | $-94M | $-165.0K | $-901.0K | |
| Stock Issued | $270.0K | · | · | · | |
| Net Stock Activity | $270.0K | · | · | · | |
| Financing Cash Flow | $217M | $89M | $104M | $189.0K | |
| Net Change in Cash | $28M | $-86M | $44M | $-55M | |
| Taxes Paid | $551.0K | $133.0K | · | · | |
| Free Cash Flow | $-99M | $-82M | $-60M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | -48.1% | -68.6% | -56.1% | · | |
| ROE | -51.9% | -76.8% | 269.5% | · | |
| ROIC | -44.3% | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 11.2 | 5.5 | 7.2 | · | |
| Quick Ratio | 3.7 | 5.3 | 7.0 | · | |
| Interest Coverage | · | · | -334.2 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $3.38 | $3.53 | $4.26 | · | |
| Cash Flow / Share | $-1.84 | $-2.55 | $-11.11 | · | |
| Cash / Share | $0.86 | $1.06 | $4.56 | · | |
| EPS (TTM) | $-1.86 | $-3.09 | $-12.40 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-100M | $-98M | $-66M | · | |
| Market Cap | $725M | $218M | $358M | · | |
| P/E | -5.3 | -2.1 | -1.1 | · | |
| P/B | 2.9 | 1.9 | 3.1 | · | |
| P / Tangible Book | 2.9 | 1.9 | 3.1 | · | |
| P / Cash Flow | -7.4 | -2.7 | -6.0 | · | |
| P / FCF | -7.3 | -2.7 | -6.0 | · | |
| Earnings Yield | -18.7% | -47.0% | -92.4% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $531.0K | |
| R&D Expense | $19M | $16M | $16M | $16M | $15M | $17M | $18M | $23M | $17M | $16M | $8M | $17M | $11M | $16M | $11M | $15M | |
| SG&A Expense | $9M | $7M | $7M | $6M | $16M | $17M | $9M | $8M | $7M | $8M | $7M | $3M | $3M | $3M | $4M | $3M | |
| Operating Expenses | $28M | $22M | $23M | $22M | $31M | $34M | $27M | $32M | $24M | $23M | $15M | $20M | $14M | $19M | $15M | $18M | |
| Operating Income | $-28M | $-22M | $-23M | $-22M | $-31M | $-34M | $-27M | $-32M | $-24M | $-23M | $-15M | $-20M | $-14M | $-19M | $-15M | $-17M | |
| Interest Expense | · | · | · | · | · | · | · | · | $35.0K | $37.0K | · | $52.0K | $53.0K | $50.0K | $54.0K | $29.0K | |
| Interest Income | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $1M | $488.0K | $590.0K | $687.0K | $676.0K | $456.0K | |
| Other Non-op | $-6.0K | $-1.0K | $9.0K | $-9.0K | $-14.0K | $-4.0K | $0 | $-3.0K | $-1.0K | $-5.0K | $-7.0K | $1.0K | $-3.0K | $-4.0K | · | · | |
| Pretax Income | $-26M | $-20M | $-21M | $-20M | $-26M | $-33M | $-26M | $-29M | $-21M | $-22M | $-14M | $-20M | $-13M | $-19M | $-15M | $-17M | |
| Net Income | $-26M | $-20M | $-21M | $-20M | $-26M | $-33M | $-26M | $-29M | $-21M | $-22M | $-14M | $-20M | $-13M | $-19M | $-15M | $-17M | |
| EPS (Basic) | $-0.30 | $-0.25 | $0.06 | $-0.33 | $-0.60 | $-0.99 | $-0.79 | $-0.89 | $-0.64 | $-0.77 | $19.84 | $-12.36 | $-8.30 | $-11.58 | $-8.86 | $-10.38 | |
| EPS (Diluted) | $-0.30 | $-0.25 | $0.06 | $-0.33 | $-0.60 | $-0.99 | $-0.79 | $-0.89 | $-0.64 | $-0.77 | $19.84 | $-12.36 | $-8.30 | $-11.58 | $-8.86 | $-10.38 | |
| Shares (Basic) | 85,626,751 | 81,183,812 | · | 60,980,867 | 43,573,628 | 33,113,991 | · | 33,063,153 | 33,001,946 | 27,979,838 | · | 1,626,734 | 1,619,547 | 1,610,793 | · | 1,643,122 | |
| Shares (Diluted) | 85,626,751 | 81,183,812 | · | 60,980,867 | 43,573,628 | 33,113,991 | · | 33,063,153 | 33,001,946 | 27,979,838 | · | 1,626,734 | 1,619,547 | 1,610,793 | · | 1,643,122 | |
| EBITDA | $-28M | $-22M | · | $-22M | $-31M | · | · | $-32M | $-24M | $-23M | · | $-20M | · | · | · | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $72M | $63M | $41M | $35M | $29M | $35M | $157M | $175M | $195M | $121M | $35M | · | · | $77M | · | |
| Short-term Investments | · | · | · | · | · | $71M | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $6M | $8M | $7M | $5M | $7M | $5M | $5M | $2M | $2M | $3M | $3M | $1M | · | · | $2M | · | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $2M | · | · | $371.0K | · | |
| Current Assets | $218M | $201M | $188M | $128M | $140M | $105M | $126M | $159M | $177M | $198M | $124M | $39M | · | · | $80M | · | |
| PP&E (Net) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $980.0K | · | · | $998.0K | · | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | · | · | $1M | · | |
| Accum. Depreciation | $887.0K | $814.0K | $741.0K | $668.0K | $596.0K | $534.0K | $474.0K | $610.0K | $527.0K | $450.0K | $381.0K | $316.0K | · | · | $133.0K | · | |
| Total Assets | $255M | $250M | $269M | $144M | $176M | $126M | $147M | $174M | $192M | $213M | $140M | $55M | · | · | $97M | · | |
| Accounts Payable | $4M | $3M | $5M | $5M | $20M | $12M | $6M | $8M | $6M | $4M | $4M | $3M | · | · | $3M | · | |
| Current Liabilities | $16M | $14M | $17M | $17M | $32M | $31M | $23M | $27M | $19M | $22M | $17M | $23M | · | · | $14M | · | |
| Capital Leases | $4M | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | $7M | $8M | $8M | · | · | $9M | · | |
| Total Liabilities | $20M | $19M | $22M | $23M | $38M | $38M | $30M | $35M | $27M | $30M | $26M | $32M | · | · | $25M | · | |
| Common Stock | $8.0K | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $0 | · | · | $0 | · | |
| Retained Earnings | $-426M | $-400M | $-380M | $-359M | $-339M | $-313M | $-280M | $-254M | $-225M | $-204M | $-182M | $-168M | · | · | $-115M | · | |
| Treasury Stock | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $17.0K | $13.0K | $13.0K | · | · | · | · | · | · | · | |
| AOCI | $-298.0K | $-142.0K | $188.0K | $89.0K | $-13.0K | $-54.0K | $-103.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $235M | $231M | $247M | $121M | $138M | $88M | $117M | $139M | $165M | $183M | $114M | $-163M | · | · | $-113M | · | |
| Liabilities + Equity | $255M | $250M | $269M | $144M | $176M | $126M | $147M | $174M | $192M | $213M | $140M | $55M | · | · | $97M | · | |
| Shares Outstanding | 78,622,604 | 74,086,737 | 73,001,350 | 54,934,275 | 53,998,492 | 33,191,865 | 33,071,261 | 33,058,447 | 33,039,911 | 32,928,141 | 26,646,378 | 1,633,206 | · | · | 1,607,185 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $74.0K | $73.0K | $73.0K | $73.0K | $62.0K | $60.0K | $75.0K | $83.0K | $77.0K | $69.0K | $77.0K | $78.0K | $59.0K | $57.0K | $58.0K | · | |
| Stock-based Comp | $6M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $3M | $2M | $804.0K | $875.0K | $969.0K | $397.0K | $521.0K | $431.0K | |
| Operating Cash Flow | $-18M | $-21M | $-20M | $-30M | $-27M | $-22M | $-28M | $-18M | $-20M | $-15M | $-14M | $-14M | $-13M | $-18M | $-17M | · | |
| CapEx | $7.0K | $35.0K | $0 | $289.0K | · | · | $0 | $83.0K | $213.0K | $185.0K | $73.0K | $3.0K | · | · | $25.0K | · | |
| Investing Cash Flow | $14M | $27M | $-102M | $35M | $-39M | $16M | $-94M | $-83.0K | $-218.0K | $-193.0K | $-73.0K | $-53.0K | · | · | $-107.0K | · | |
| Stock Issued | $25M | $143.0K | $-1.0K | $101.0K | $0 | $170.0K | · | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $143.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $24M | $2M | $144M | $52.0K | $73M | $11.0K | $-97.0K | $-72.0K | $291.0K | $89M | $100M | $4M | $-94.0K | $-98.0K | $-81.0K | · | |
| Net Change in Cash | $21M | $9M | $22M | $6M | $7M | $-6M | $-122M | $-18M | $-20M | $74M | $86M | $-10M | $-13M | $-18M | $-17M | · | |
| Free Cash Flow | · | $-21M | · | · | · | · | · | · | · | $-15M | · | · | · | · | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -12.0% | -10.7% | · | -12.8% | -14.2% | · | · | -25.8% | -22.1% | -20.3% | · | -73.5% | · | · | · | · | |
| ROE | -13.9% | -12.6% | · | -15.6% | -17.2% | · | · | 251.2% | -25.8% | -23.7% | · | 24.7% | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.9 | 14.2 | · | 7.4 | 4.4 | · | · | 5.9 | 9.4 | 9.2 | · | 1.7 | · | · | · | · | |
| Quick Ratio | 5.9 | 5.1 | · | 2.4 | 1.1 | · | · | 5.9 | 9.3 | 9.0 | · | 1.5 | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -672.9 | -629.5 | · | -389.9 | · | · | · | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.99 | $3.12 | · | $2.20 | $2.56 | · | · | $4.21 | $4.99 | $5.56 | · | $-99.69 | · | · | · | · | |
| Cash Flow / Share | · | $-0.26 | · | · | · | · | · | · | · | $-0.53 | · | · | · | · | · | · | |
| Cash / Share | $1.18 | $0.97 | · | $0.75 | $0.66 | · | · | $4.75 | $5.30 | $5.92 | · | $21.71 | · | · | · | · | |
| EPS (TTM) | $-0.82 | $-1.12 | · | $-2.71 | $-3.27 | $-3.29 | · | $17.54 | $6.07 | $-1.59 | · | $-41.10 | $-39.12 | · | · | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-87M | $-88M | · | $-105M | $-114M | $-105M | · | $-87M | $-77M | $-69M | · | $-67M | $-64M | $-65M | · | · | |
| Market Cap | $366M | $425M | · | $365M | $217M | · | · | $299M | $530M | $516M | · | · | · | · | · | · | |
| P/E | -5.7 | -5.1 | · | -2.5 | -1.2 | -1.1 | · | 0.5 | 2.6 | -9.9 | · | · | · | · | · | · | |
| P/B | 1.6 | 1.8 | · | 3.0 | 1.6 | · | · | 2.1 | 3.2 | 2.8 | · | · | · | · | · | · | |
| P / Tangible Book | 1.6 | 1.8 | · | 3.0 | 1.6 | 1.3 | · | 2.1 | 3.2 | 2.8 | · | · | · | · | · | · | |
| P / Cash Flow | · | -20.1 | · | · | · | · | · | · | · | -34.7 | · | · | · | · | · | · | |
| Earnings Yield | -17.6% | -19.5% | · | -40.8% | -81.3% | -94.8% | · | 194.0% | 37.8% | -10.1% | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | · | · | · | $654.0K |
| Net Income | $-100M | $-98M | $-66M | $-59M |
| Diluted EPS | $-1.86 | $-3.09 | $-12.40 | $-36.36 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Current Ratio | 11.2 | 5.5 | 7.2 | · |
| Quick Ratio | 3.7 | 5.3 | 7.0 | · |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | $-99M | $-82M | $-60M | · |
Institutional owners (13F) 148 filers · $459.4M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
148
Value held
$459.4M
New positions
28
Exited positions
19
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 28 (+5 vs prior Q) | 19 (-5 vs prior Q) | 58 (0 vs prior Q) | 40 (+3 vs prior Q) | +5.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $38,670,499 | 3,894,310 | 8.42% | Shares |
| MONTANOVA CAPITAL, LLC | $29,718,451 | 6,384,200 | 6.47% | Shares |
| JANUS HENDERSON GROUP PLC | $28,510,358 | 4,976,429 | 6.21% | Shares |
| Affinity Asset Advisors, LLC | $27,034,429 | 5,807,611 | 5.88% | Shares |
| BlackRock, Inc. | $26,717,165 | 5,739,455 | 5.82% | Shares |
| RA CAPITAL MANAGEMENT, L.P. | $23,275,000 | 5,000,000 | 5.07% | Shares |
| Frazier Life Sciences Management, L.P. | $22,459,095 | 4,824,725 | 4.89% | Shares |
| STATE STREET CORP | $20,271,394 | 4,354,757 | 4.41% | Shares |
| Vestal Point Capital, LP | $20,109,600 | 4,320,000 | 4.38% | Shares |
| Paradigm Biocapital Advisors LP | $19,436,403 | 4,175,382 | 4.23% | Shares |
| ORBIMED ADVISORS LLC | $18,377,242 | 3,947,850 | 4.00% | Shares |
| CITADEL ADVISORS LLC | $18,147,843 | 3,898,570 | 3.95% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $14,551,032 | 3,125,893 | 3.17% | Shares |
| MILLENNIUM MANAGEMENT LLC | $13,190,510 | 2,833,622 | 2.87% | Shares |
| Woodline Partners LP | $11,639,976 | 2,500,532 | 2.53% | Shares |
| Balyasny Asset Management L.P. | $11,231,314 | 2,412,742 | 2.44% | Shares |
| GOLDMAN SACHS GROUP INC | $10,006,444 | 2,149,612 | 2.18% | Shares |
| 683 Capital Management, LLC | $8,728,124 | 1,875,000 | 1.90% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $8,138,547 | 1,747,959 | 1.77% | Shares |
| ADAR1 Capital Management, LLC | $7,289,497 | 1,565,950 | 1.59% | Shares |
| Avoro Capital Advisors LLC | $6,932,175 | 1,489,189 | 1.51% | Shares |
| Qube Research & Technologies Ltd | $6,406,313 | 1,376,222 | 1.39% | Shares |
| Nantahala Capital Management, LLC | $6,051,500 | 1,300,000 | 1.32% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $5,992,745 | 1,287,185 | 1.30% | Shares |
| Spruce Street Capital LP | $4,322,600 | 928,593 | 0.94% | Shares |
| Blackstone Inc. | $4,217,109 | 904,959 | 0.92% | Shares |
| NORTHERN TRUST CORP | $4,037,705 | 867,391 | 0.88% | Shares |
| Aberdeen Group plc | $3,142,553 | 675,092 | 0.68% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,857,360 | 613,826 | 0.62% | Shares |
| Ikarian Capital, LLC | $2,388,066 | 513,011 | 0.52% | Shares |
| BANK OF AMERICA CORP /DE/ | $2,282,490 | 490,331 | 0.50% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,004,890 | 430,696 | 0.44% | Shares |
| MORGAN STANLEY | $1,839,200 | 395,102 | 0.40% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $1,807,993 | 388,398 | 0.39% | Shares |
| DAFNA Capital Management LLC | $1,755,210 | 377,059 | 0.38% | Shares |
| UBS Group AG | $1,648,074 | 354,044 | 0.36% | Shares |
| Trexquant Investment LP | $1,465,818 | 314,891 | 0.32% | Shares |
| Squarepoint Ops LLC | $1,372,173 | 294,774 | 0.30% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $1,194,757 | 256,661 | 0.26% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $1,165,449 | 250,365 | 0.25% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $942,093 | 202,383 | 0.21% | Shares |
| Nuveen, LLC | $932,941 | 200,417 | 0.20% | Shares |
| Bank of New York Mellon Corp | $855,975 | 183,883 | 0.19% | Shares |
| TWO SIGMA ADVISERS, LP | $807,309 | 81,300 | 0.18% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $803,495 | 172,609 | 0.17% | Shares |
| Susquehanna Portfolio Strategies, LLC | $749,744 | 161,062 | 0.16% | Shares |
| Privium Fund Management B.V. | $722,300 | 155,000 | 0.16% | Shares |
| XTX Topco Ltd | $677,563 | 145,556 | 0.15% | Shares |
| FMR LLC | $657,035 | 141,146 | 0.14% | Shares |
| BOOTHBAY FUND MANAGEMENT, LLC | $634,835 | 136,377 | 0.14% | Shares |
Company insiders 18 insiders · 9 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Richard Nolan Townsend | Chief Executive Officer | Sept. 24, 2026 A | 376,778 | 0 | 8 | $-655,514 |
| Louis Edward Tamayo | Chief Financial Officer | Sept. 24, 2026 A | 92,907 | 0 | 2 | $-41,052 |
| Kyle Rasbach | Chief Financial Officer | Jan. 17, 2025 A | 40,875 | 0 | 0 | $0 |
| Jose Manuel Otero | Chief Operating Officer | Sept. 24, 2026 A | 138,288 | 0 | 8 | $-85,566 |
| Narinder Pal Bhalla | Chief Medical Officer | Sept. 24, 2026 A | 84,908 | 0 | 1 | $-98,593 |
| Tai Sandi See | Chief Development Officer | Nov. 18, 2025 S | 65,476 | 0 | 3 | $-38,364 |
| Jenny Robertson | Chief Legal Officer | Nov. 18, 2025 S | 68,381 | 0 | 3 | $-36,636 |
| Eric Adler | Chief Medical Officer | Nov. 18, 2025 S | 72,646 | 0 | 3 | $-35,959 |
| Paul Mccormac | Chief Technical Officer | Nov. 7, 2023 C | 17,349 | 0 | 0 | $0 |
| Brenda Cooperstone | Director | June 25, 2026 A | · | 0 | 0 | $0 |
| Tolga Tanguler | Director | June 25, 2026 A | · | 0 | 0 | $0 |
| Timothy Van Hauwermeiren | Director | June 25, 2026 A | · | 0 | 0 | $0 |
| Mette Kirstine Agger | Director | June 25, 2026 A | · | 0 | 0 | $0 |
| Steven Altschuler | Director | June 25, 2026 A | · | 0 | 0 | $0 |
| Reinaldo M Diaz | Director | June 25, 2026 A | · | 0 | 0 | $0 |
| CHOLMONDELEY PAULA H | Director | June 25, 2026 A | 30,627 | 0 | 0 | $0 |
| Laura Sepp-Lorenzino | Director | April 28, 2026 A | · | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10% owner | Nov. 7, 2023 C | 1,835,959 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 24 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0.63% | 71,124 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.07% | 239,703 SH | Sept. 11, 2026 | Daily |
| LABU · Direxion Shares ETF Trust | 0.07% | 82,556 NS | July 31, 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0.03% | 139,450 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 61,750 SH | Aug. 19, 2026 | Daily |
| IBB · iShares Trust | 0.02% | 463,718 SH | Sept. 11, 2026 | Daily |
| PWS · Pacer Funds Trust | 0.02% | 1,128 NS | July 31, 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.02% | 5,711 SH | Oct. 1, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,812,282 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 407,613 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 33,862 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 62,956 SH | Oct. 1, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 254,051 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 171,599 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 1,683 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 5,030 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 91,142 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 19,515 SH | Sept. 10, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.00% | 10,699 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.00% | 10,265 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 715,087 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,335,144 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5,013 SH | Aug. 19, 2026 | Daily |
| IWN · iShares Trust | · | 661,270 SH | Sept. 11, 2026 | Daily |
LXEO Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 16 analysts
BUY
Median target
$20.00
+466.6%
8 50.0%
Strong Buy
7 43.8%
Buy
1 6.2%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
10 analysts · 2026-09-29Mean target $20.30 +475.1%
← Below all targets
Current price $3.53
Low$9.00
Mean$20.30
High$30.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| SCTX | · | · | · | · | · | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
| UPB | $1.47B | -10.2 | 20.4% | -5026.0% | -38.3% | · |
| RCKT | · | · | · | · | · | · |
| FATE | $113M | -0.9 | -51.2% | -2051.1% | -58.2% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 12, 2026